{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:51:16Z","timestamp":1785887476921,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["F31-NS137783"],"award-info":[{"award-number":["F31-NS137783"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS113912-05"],"award-info":[{"award-number":["R01-NS113912-05"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1-TR002016"],"award-info":[{"award-number":["TL1-TR002016"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-026-00822-5","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:54:07Z","timestamp":1780156447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["L-DOPA influences transferrin-dependent iron release at the blood-brain barrier"],"prefix":"10.1186","volume":"23","author":[{"given":"Rebecka O.","family":"Serpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kondaiah","family":"Palsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Laukhuff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir S.","family":"Spiegelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Elcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"1\u20132","key":"822_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbrc.2017.10.083","volume":"494","author":"KA Duck","year":"2017","unstructured":"Duck KA, Simpson IA, Connor JR. Regulatory mechanisms for iron transport across the blood-brain barrier. Biochem Biophys Res Commun. 2017;494(1\u20132):70\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"822_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00018-014-1771-4","volume":"72","author":"RC McCarthy","year":"2015","unstructured":"McCarthy RC, Kosman DJ. Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy. Cell Mol Life Sci. 2015;72(4):709\u201327.","journal-title":"Cell Mol Life Sci"},{"key":"822_CR3","doi-asserted-by":"publisher","first-page":"593026","DOI":"10.3389\/fphys.2020.593026","volume":"11","author":"S Al-Bachari","year":"2020","unstructured":"Al-Bachari S, et al. Blood-Brain Barrier Leakage Is Increased in Parkinson\u2019s Disease. Front Physiol. 2020;11:593026.","journal-title":"Front Physiol"},{"issue":"46","key":"822_CR4","doi-asserted-by":"publisher","first-page":"45663","DOI":"10.1021\/acsomega.4c06546","volume":"9","author":"M Khalid Iqbal","year":"2024","unstructured":"Khalid Iqbal M, et al. The Impact of the Blood\u2013Brain Barrier and Its Dysfunction in Parkinson\u2019s Disease: Contributions to Pathogenesis and Progression. ACS Omega. 2024;9(46):45663\u201372.","journal-title":"ACS Omega"},{"key":"822_CR5","doi-asserted-by":"crossref","unstructured":"Elkhial RT, et al. The enhanced Wnt\/\u03b2-Catenin pathway upregulation by Sacubitril\/Valsartan via neprilysin inhibition compared to valsartan in the rotenone induced Parkinson\u2019s disease rat model. Neuropharmacology. 2025:110734.","DOI":"10.1016\/j.neuropharm.2025.110734"},{"issue":"2","key":"822_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","volume":"47","author":"K Wakabayashi","year":"2013","unstructured":"Wakabayashi K, et al. The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders. Mol Neurobiol. 2013;47(2):495\u2013508.","journal-title":"Mol Neurobiol"},{"issue":"11","key":"822_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, et al. Global, regional, and national burden of Parkinson\u2019s disease,1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol"},{"key":"822_CR8","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, et al. Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ. 2025;388:e080952.","journal-title":"BMJ"},{"issue":"8","key":"822_CR9","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/mds.29062","volume":"37","author":"G Du","year":"2022","unstructured":"Du G, et al. Dynamics of Nigral Iron Accumulation in Parkinson\u2019s Disease: From Diagnosis to Late Stage. Mov Disord. 2022;37(8):1654\u201362.","journal-title":"Mov Disord"},{"issue":"1","key":"822_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41531-025-00911-6","volume":"11","author":"M L\u00f3pez-Aguirre","year":"2025","unstructured":"L\u00f3pez-Aguirre M, et al. Nigrostriatal iron accumulation in the progression of Parkinson\u2019s disease. npj Parkinson\u2019s Disease. 2025;11(1):72.","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"1","key":"822_CR11","doi-asserted-by":"publisher","first-page":"29651","DOI":"10.1038\/srep29651","volume":"6","author":"CT Hong","year":"2016","unstructured":"Hong CT, et al. Newly Diagnosed Anemia Increases Risk of Parkinson\u2019s disease: A Population-Based Cohort Study. Sci Rep. 2016;6(1):29651.","journal-title":"Sci Rep"},{"issue":"17","key":"822_CR12","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1212\/WNL.0b013e3181bd80c1","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica R, et al. Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology. 2009;73(17):1381\u20137.","journal-title":"Neurology"},{"issue":"1","key":"822_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1006948027674","volume":"20","author":"T Moos","year":"2000","unstructured":"Moos T, Morgan EH. Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol. 2000;20(1):77\u201395.","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"822_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jnc.14834","volume":"152","author":"B Chiou","year":"2020","unstructured":"Chiou B, et al. Transferrin and H-ferritin involvement in brain iron acquisition during postnatal development: impact of sex and genotype. J Neurochem. 2020;152(3):381\u201396.","journal-title":"J Neurochem"},{"key":"822_CR15","doi-asserted-by":"crossref","unstructured":"Leitner DF, Connor JR. Functional roles of transferrin in the brain. Biochimica et Biophysica Acta (BBA) - General Subjects. 2012;1820(3):393\u2013402.","DOI":"10.1016\/j.bbagen.2011.10.016"},{"issue":"11","key":"822_CR16","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1177\/0271678X18783372","volume":"39","author":"B Chiou","year":"2019","unstructured":"Chiou B, et al. Endothelial cells are critical regulators of iron transport in a model of the human blood-brain barrier. J Cereb Blood Flow Metab. 2019;39(11):2117\u201331.","journal-title":"J Cereb Blood Flow Metab"},{"key":"822_CR17","doi-asserted-by":"crossref","unstructured":"Baringer S, et al. Apo- and holo- transferrin differentially interact with ferroportin and hephaestin to regulate iron release at the blood-brain barrier. Res Sq. 2023.","DOI":"10.21203\/rs.3.rs-2429356\/v1"},{"issue":"1","key":"822_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12987-022-00345-9","volume":"19","author":"SL Baringer","year":"2022","unstructured":"Baringer SL, et al. Regulation of brain iron uptake by apo- and holo-transferrin is dependent on sex and delivery protein. Fluids Barriers CNS. 2022;19(1):49.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"822_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/jcbfm.2014.168","volume":"35","author":"IA Simpson","year":"2015","unstructured":"Simpson IA, et al. A novel model for brain iron uptake: introducing the concept of regulation. J Cereb Blood Flow Metab. 2015;35(1):48\u201357.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"822_CR20","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/sj.emboj.7601735","volume":"26","author":"I De Domenico","year":"2007","unstructured":"De Domenico I, et al. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. Embo j. 2007;26(12):2823\u201331.","journal-title":"Embo j"},{"issue":"1","key":"822_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jnc.14676","volume":"150","author":"JL Billings","year":"2019","unstructured":"Billings JL, et al. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson\u2019s disease. J Neurochem. 2019;150(1):88\u2013106.","journal-title":"J Neurochem"},{"issue":"9","key":"822_CR22","first-page":"e93123","volume":"17","author":"A Li","year":"2025","unstructured":"Li A, et al. A Review of the Recent Advances in the Pharmacological Management of Parkinson\u2019s Disease. Cureus. 2025;17(9):e93123.","journal-title":"Cureus"},{"key":"822_CR23","doi-asserted-by":"publisher","first-page":"101896","DOI":"10.1016\/j.redox.2021.101896","volume":"41","author":"L Ma","year":"2021","unstructured":"Ma L, et al. Parkinson\u2019s disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies. Redox Biol. 2021;41:101896.","journal-title":"Redox Biol"},{"issue":"Pt 4","key":"822_CR24","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/brain\/aww022","volume":"139","author":"DJ Hare","year":"2016","unstructured":"Hare DJ, Double KL. Iron and dopamine: a toxic couple. Brain. 2016;139(Pt 4):1026\u201335.","journal-title":"Brain"},{"issue":"1","key":"822_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1021\/acschemneuro.1c00693","volume":"13","author":"S Alhassen","year":"2022","unstructured":"Alhassen S, Senel M, Alachkar A. Surface Plasmon Resonance Identifies High-Affinity Binding of l-DOPA to Siderocalin\/Lipocalin-2 through Iron\u2013Siderophore Action: Implications for Parkinson\u2019s Disease Treatment. ACS Chem Neurosci. 2022;13(1):158\u201365.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"822_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/archneur.1991.00530130039017","volume":"48","author":"TS Elizan","year":"1991","unstructured":"Elizan TS, Moros DA, Yahr MD. Early Combination of Selegiline and Low-Dose Levodopa as Initial Symptomatic Therapy in Parkinson\u2019s Disease: Experience in 26 Patients Receiving Combined Therapy for 26 Months. Arch Neurol. 1991;48(1):31\u20134.","journal-title":"Arch Neurol"},{"key":"822_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bbr.2018.03.002","volume":"347","author":"H Tsunekawa","year":"2018","unstructured":"Tsunekawa H, et al. Selegiline increases on time without exacerbation of dyskinesia in 6-hydroxydopamine-lesioned rats displaying l-Dopa-induced wearing-off and abnormal involuntary movements. Behav Brain Res. 2018;347:350\u20139.","journal-title":"Behav Brain Res"},{"key":"822_CR28","doi-asserted-by":"crossref","unstructured":"Naoi M, Maruyama W, Shamoto-Nagai M. Neuroprotective function of rasagiline and selegiline, inhibitors of type B monoamine oxidase, and role of monoamine oxidases in synucleinopathies. Int J Mol Sci. 2022;23(19).","DOI":"10.3390\/ijms231911059"},{"issue":"2","key":"822_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00702-005-0309-1","volume":"113","author":"K Takahata","year":"2006","unstructured":"Takahata K, et al. Effects of selegiline on antioxidant systems in the nigrostriatum in rat. J Neural Transm (Vienna). 2006;113(2):151\u20138.","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"822_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrn1883","volume":"7","author":"MB Youdim","year":"2006","unstructured":"Youdim MB, Edmondson D, Tipton KF. The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci. 2006;7(4):295\u2013309.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"822_CR31","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stemcr.2019.05.008","volume":"12","author":"EH Neal","year":"2019","unstructured":"Neal EH, Simplified A, et al. Fully Defined Differentiation Scheme for Producing Blood-Brain Barrier Endothelial Cells from Human iPSCs. Stem Cell Rep. 2019;12(6):1380\u20138.","journal-title":"Stem Cell Rep"},{"issue":"2","key":"822_CR32","doi-asserted-by":"publisher","first-page":"102868","DOI":"10.1016\/j.jbc.2022.102868","volume":"299","author":"K Palsa","year":"2023","unstructured":"Palsa K, et al. Exosomes are involved in iron transport from human blood-brain barrier endothelial cells and are modified by endothelial cell iron status. J Biol Chem. 2023;299(2):102868.","journal-title":"J Biol Chem"},{"key":"822_CR33","doi-asserted-by":"publisher","first-page":"685822","DOI":"10.3389\/fneur.2021.685822","volume":"12","author":"L Ferguson","year":"2021","unstructured":"Ferguson L, et al. Sex Differences in Neurophysiological Changes Following Voluntary Exercise in Adolescent Rats. Front Neurol. 2021;12:685822.","journal-title":"Front Neurol"},{"issue":"9","key":"822_CR34","doi-asserted-by":"publisher","first-page":"e0221952","DOI":"10.1371\/journal.pone.0221952","volume":"14","author":"V Ravi","year":"2019","unstructured":"Ravi V, et al. Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms. PLoS ONE. 2019;14(9):e0221952.","journal-title":"PLoS ONE"},{"issue":"4","key":"822_CR35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0306-4522(03)00590-6","volume":"121","author":"JR Burdo","year":"2003","unstructured":"Burdo JR, et al. Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system. Neuroscience. 2003;121(4):883\u201390.","journal-title":"Neuroscience"},{"issue":"1","key":"822_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/pr10010132","volume":"10","author":"\u0130 Gulcin","year":"2022","unstructured":"Gulcin \u0130, Alwasel SH, Ions M. Metal Chelators and Metal Chelating Assay as Antioxidant Method. Processes. 2022;10(1):132.","journal-title":"Processes"},{"key":"822_CR37","doi-asserted-by":"crossref","unstructured":"Abeyawardhane DL, Lucas HR. Iron redox chemistry and implications in the Parkinson\u2019s disease brain. Oxid Med Cell Longev. 2019:4609702.","DOI":"10.1155\/2019\/4609702"},{"key":"822_CR38","doi-asserted-by":"crossref","unstructured":"Harris ZL, et al. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci. 1999;96(19):10812\u201310817.","DOI":"10.1073\/pnas.96.19.10812"},{"issue":"11","key":"822_CR39","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1074\/jbc.RA118.005142","volume":"294","author":"AC Dlouhy","year":"2019","unstructured":"Dlouhy AC, et al. Fluorescence resonance energy transfer links membrane ferroportin, hephaestin but not ferroportin, amyloid precursor protein complex with iron efflux. J Biol Chem. 2019;294(11):4202\u201314.","journal-title":"J Biol Chem"},{"issue":"3","key":"822_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/biomedicines12030595","volume":"12","author":"M Kulaszy\u0144ska","year":"2024","unstructured":"Kulaszy\u0144ska M, Kwiatkowski S, Skonieczna-\u017bydecka K. The Iron Metabolism with a Specific Focus on the Functioning of the Nervous System. Biomedicines. 2024;12(3):595.","journal-title":"Biomedicines"},{"issue":"4","key":"822_CR41","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41380-023-02399-z","volume":"29","author":"S Levi","year":"2024","unstructured":"Levi S, et al. Iron imbalance in neurodegeneration. Mol Psychiatry. 2024;29(4):1139\u201352.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"822_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03033137","volume":"5","author":"M Asanuma","year":"2003","unstructured":"Asanuma M, Miyazaki I, Ogawa N. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson\u2019s disease. Neurotox Res. 2003;5(3):165\u201376.","journal-title":"Neurotox Res"},{"issue":"1","key":"822_CR43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41531-025-01089-7","volume":"11","author":"ML Bolen","year":"2025","unstructured":"Bolen ML, et al. Iron mishandling in the brain and periphery in Parkinson\u2019s disease. npj Parkinson\u2019s Disease. 2025;11(1):246.","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"5\u20136","key":"822_CR44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00702-022-02505-5","volume":"129","author":"PB Foley","year":"2022","unstructured":"Foley PB, Hare DJ, Double KL. A brief history of brain iron accumulation in Parkinson disease and related disorders. J Neural Transm (Vienna). 2022;129(5\u20136):505\u201320.","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"822_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10571-024-01459-4","volume":"44","author":"W Zeng","year":"2024","unstructured":"Zeng W, et al. Iron Deposition in Parkinson\u2019s Disease: A Mini-Review. Cell Mol Neurobiol. 2024;44(1):26.","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"822_CR46","doi-asserted-by":"publisher","first-page":"e89003","DOI":"10.1371\/journal.pone.0089003","volume":"9","author":"RC McCarthy","year":"2014","unstructured":"McCarthy RC, Kosman DJ. Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells. PLoS ONE. 2014;9(2):e89003.","journal-title":"PLoS ONE"},{"key":"822_CR47","first-page":"65","volume":"12","author":"RC McCarthy","year":"2014","unstructured":"McCarthy RC, Kosman DJ. Activation of C6 glioblastoma cell ceruloplasmin expression by neighboring human brain endothelia-derived interleukins in an in vitro blood-brain barrier model system. Cell Commun Signal. 2014;12:65.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"822_CR48","doi-asserted-by":"publisher","first-page":"e70389","DOI":"10.1111\/jnc.70389","volume":"170","author":"RO Serpa","year":"2026","unstructured":"Serpa RO, et al. Sex and Diet Biased Effect of L-DOPA on Iron Accumulation in the Ventral Midbrain. J Neurochem. 2026;170(3):e70389.","journal-title":"J Neurochem"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00822-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:29:34Z","timestamp":1785886174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00822-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00822-5","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"95"}}